Dorothy Margolskee

Investing Profile

Sweet spot: $1.5M Range: $100K–$5M Fund: $668M

Foresite Capital thesis

"Foresite Capital has been a visionary partner." Serge Saxonov, CEO & Co-Founder 10x Genomics (See Disclosures) “Foresite Capital’s deep industry knowledge and in-house expertise has helped fuel our mission to outsmart cancer resistance.” Tim Clackson Theseus Pharmaceuticals (See Disclosures) "The Foresite team contributed meaningful scientific and strategic insights that supported our path from concept to acquisition in just over two years. Their partnership allowed our small team to move more quickly and decisively than we could have alone." Chris LeMasters XinThera (See Disclosures) "The Fo

Sector and stage focus

  • Series B: Consumer Health, BioTech, Health & Hospital Services, Digital Health, Health IT
  • Series A: Consumer Health, BioTech, Health IT, Health & Hospital Services, Digital Health
  • Seed: BioTech, Consumer Health, Health IT, Digital Health, Health & Hospital Services

Is Dorothy Margolskee a fit for your round?

Upload your pitch deck and see whether Dorothy Margolskee appears in your top 20 matches.

Find investors for your deck